Agonist/antagonist compounds' mechanism of action on estrogen receptor-positive breast cancer: A system-level investigation assisted by meta-analysis

Informatics in Medicine Unlocked - Tập 31 - Trang 100985 - 2022
Zeynab Piryaei1,2, Zahra Salehi3,4, Mohammad Reza Tahsili5, Esmaeil Ebrahimie6,7,8, Mansour Ebrahimi5, Kaveh Kavousi2
1Department of Bioinformatics, Kish International Campus University of Tehran, Kish, Iran
2Laboratory of Complex Biological Systems and Bio-informatics (CBB), Department of Bioinformatics, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Iran
3Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5Department of Biology, Faculty of Science, University of Qom, Qom, Iran
6Institute of Biotechnology, Shiraz University, Shiraz, Iran
7School of Animal and Veterinary Sciences, The University of Adelaide, South Australia, Adelaide, Australia
8Genomics Research Platform, School of Life Sciences, La Trobe University, Melbourne, Victoria, Australia

Tài liệu tham khảo

Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J Clin, 71, 209, 10.3322/caac.21660 Siegel, 2018, Cancer statistics, 2018, CA A Cancer J Clin, 68, 7, 10.3322/caac.21442 Dai, 2015, Breast cancer intrinsic subtype classification, clinical use and future trends, Am J Cancer Res, 5, 2929 Hon, 2016, Breast cancer molecular subtypes: from TNBC to QNBC, Am J Cancer Res, 6, 1864 Brosens, 2004, Steroid receptor action, Best Pract Res Clin Obstet Gynaecol, 18, 265, 10.1016/j.bpobgyn.2004.01.006 Fuller, 1991, The steroid receptor superfamily: mechanisms of diversity, Faseb J, 5, 3092, 10.1096/fasebj.5.15.1743440 Guan, 2019, Therapeutic ligands antagonize estrogen receptor function by impairing its mobility, Cell, 178, 949, 10.1016/j.cell.2019.06.026 Baran-Gale, 2016, An integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response in MCF-7 breast cancer cells, RNA, 22, 1592, 10.1261/rna.056895.116 Jonsson, 2015, Single-molecule sequencing reveals estrogen-regulated clinically relevant lncRNAs in breast cancer, Mol Endocrinol, 29, 1634, 10.1210/me.2015-1153 Gertz, 2012, Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner, Genome Res, 22, 2153, 10.1101/gr.135681.111 Leek, 2010, Tackling the widespread and critical impact of batch effects in high-throughput data, Nat Rev Genet, 11, 733, 10.1038/nrg2825 Rothman, 2008, vol. 3 Baccarella, 2018, Empirical assessment of the impact of sample number and read depth on RNA-Seq analysis workflow performance, BMC Bioinf, 19, 423, 10.1186/s12859-018-2445-2 Huang, 2016, SMAD7 polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies, Oncotarget, 7, 75561, 10.18632/oncotarget.12285 Jouybari, 2019, A meta-analysis of zinc levels in breast cancer, J Trace Elem Med Biol, 56, 90, 10.1016/j.jtemb.2019.06.017 Haidich, 2010, Meta-analysis in medical research, Hippokratia, 14, 29 Cummings, 2019, Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis, JAMA Intern Med, 179, 1491, 10.1001/jamainternmed.2019.2779 Lu, 2018, 308189 Jung, 2017, Meta-analysis of microarray and RNA-Seq gene expression datasets for carcinogenic risk: an assessment of Bisphenol A, Mol Cell Toxicol, 13, 239, 10.1007/s13273-017-0026-5 Katiyar, 2018, Identification of shared molecular signatures indicate the susceptibility of endometriosis to multiple sclerosis, Front Genet, 9, 10.3389/fgene.2018.00042 Tsuyuzaki, 2013 Marot, 2020, metaRNASeq: differential meta-analysis of RNA-seq data, Dim (Param), 1, 3 Moulos, 2015, Systematic integration of RNA-Seq statistical algorithms for accurate detection of differential gene expression patterns, Nucleic Acids Res, 43, e25, 10.1093/nar/gku1273 2017, vol. 45, D12 Cochrane, 2013, Facing growth in the European nucleotide archive, Nucleic Acids Res, 41, D30, 10.1093/nar/gks1175 Andrews, 2010 Bolger, 2014, Trimmomatic: a flexible trimmer for Illumina sequence data, Bioinformatics, 30, 2114, 10.1093/bioinformatics/btu170 HISAT: a fast spliced aligner with low memory requirements | Nature Methods n.d. https://www.nature.com/articles/nmeth.3317?report=reader (accessed March 29, 2022). Kovaka, 2019, Transcriptome assembly from long-read RNA-seq alignments with StringTie2, Genome Biol, 20, 278, 10.1186/s13059-019-1910-1 Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 Tarazona Mortazavi, 2008, Mapping and quantifying mammalian transcriptomes by RNA-Seq, Nat Methods, 5, 621, 10.1038/nmeth.1226 Robinson, 2010, A scaling normalization method for differential expression analysis of RNA-seq data, Genome Biol, 11, R25, 10.1186/gb-2010-11-3-r25 Kuleshov, 2016, Enrichr: a comprehensive gene set enrichment analysis web server 2016 update, Nucleic Acids Res, 44, 10.1093/nar/gkw377 Ogata, 1999, KEGG: Kyoto Encyclopedia of genes and genomes, Nucleic Acids Res, 27, 29, 10.1093/nar/27.1.29 Kumar, 2015, MetaRNA-seq: an interactive tool to browse and annotate metadata from RNA-seq studies, BioMed Res Int, 2015, 10.1155/2015/318064 Ma T, Liang F, Tseng G. Biomarker detection and categorization in RNA-seq meta-analysis using Bayesian hierarchical model n.d. https://matianzhou.github.io/files/preprints/BayesMetaSeq.pdf. Nguyen, 2020, Deregulated mitochondrial DNA in diseases, DNA Cell Biol, 39, 1385, 10.1089/dna.2019.5220 Fuentes-Retamal, 2020, Complex mitochondrial dysfunction induced by TPP+-Gentisic acid and mitochondrial translation inhibition by doxycycline evokes synergistic lethality in breast cancer cells, Cells, 9, 407, 10.3390/cells9020407 Harris, 2020, Chemoprevention of breast cancer by cyclooxygenase and lipoxygenase inhibitors, World Acad Sci J, 2, 14 Shao, 2020, Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers, J Transl Med, 18, 94, 10.1186/s12967-020-02271-6 Muciño-Olmos, 2020, Unveiling functional heterogeneity in breast cancer multicellular tumor spheroids through single-cell RNA-seq, Sci Rep, 10, 12728, 10.1038/s41598-020-69026-7 Beadnell, 2018, Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer, Cancer Metastasis Rev, 37, 615, 10.1007/s10555-018-9772-7 Huang, 2020 Huang, 2019, Overexpressed BSG related to the progression of lung adenocarcinoma with high-throughput data-mining, immunohistochemistry, in vitro validation and in silico investigation, Am J Transl Res, 11, 4835 Norouzi, 2020, Comparative proteomics study of proteins involved in induction of higher rates of cell death in mitoxantrone-resistant breast cancer cells MCF-7/MX exposed to TNF-α, Iran J Basic Med Sci, 23, 663 Bajbouj, 2020, Estrogen signaling induces mitochondrial dysfunction-associated autophagy and senescence in breast cancer cells, Biology, 9, 68, 10.3390/biology9040068 Dahary, 2019, Genome analysis and knowledge-driven variant interpretation with TGex, BMC Med Genom, 12, 200, 10.1186/s12920-019-0647-8 Lencinas, 2013, Olfactomedin-1 activity identifies a cell invasion checkpoint during epithelial-mesenchymal transition in the chick embryonic heart, Dis Models Mech, 6, 632 Chen, 2019, Role of stanniocalcin-1 in breast cancer (Review), Oncol Lett, 18, 3946 Fahim, 2020, Inflammatory breast carcinoma: elevated microRNA miR-181b-5p and reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p expression as potential biomarkers with diagnostic value, Biomolecules, 10, 1059, 10.3390/biom10071059 Sanchez-Fernandez, 2020, Nursing genetic research: new insights linking breast cancer genetics and bone density, Healthcare, 8, 172, 10.3390/healthcare8020172 Li, 2016, Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells, Oncotarget, 7, 84645, 10.18632/oncotarget.13175 Majorini, 2020, Infiltrating mast cell–mediated stimulation of estrogen receptor activity in breast cancer cells promotes the luminal phenotype, Cancer Res, 80, 2311, 10.1158/0008-5472.CAN-19-3596 Qiu, 2019, Weighted gene co-expression network analysis reveals modules and hub genes associated with the development of breast cancer, Med, 98 Wardell, 2020, Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy, Breast Cancer Res Treat, 179, 67, 10.1007/s10549-019-05454-y Kim, 2020, The expression pattern of epidermal differentiation marker keratin 10 in the normal human breast and breast cancer cells, J Histochem Cytochem, 68, 561, 10.1369/0022155420940220 Xu, 2020, Identification of candidate genes associated with breast cancer prognosis, DNA Cell Biol, 39, 1205, 10.1089/dna.2020.5482 Joosse, 2012, Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells, Clin Cancer Res, 18, 993, 10.1158/1078-0432.CCR-11-2100 Moradpoor, 2020, Identification and validation of stage-associated PBMC biomarkers in breast cancer using MS-based proteomics, Front Oncol, 10, 10.3389/fonc.2020.01101 Persson, 2020, Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer, Int J Cancer, 146, 3343, 10.1002/ijc.32927 Abolghasemi, 2020, Critical roles of long noncoding RNAs in breast cancer, J Cell Physiol, 235, 5059, 10.1002/jcp.29442 Hongcan Wang, 2020, Elevated long noncoding RNA MALAT-1 expression is predictive of poor prognosis in patients with breast cancer: a meta-analysis, Biosci Rep, 40 Zhang, 2020, Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer, RNA Biol, 17, 1590, 10.1080/15476286.2020.1777769 Stender, 2017, Structural and molecular mechanisms of cytokine-mediated endocrine resistance in human breast cancer cells, Mol Cell, 65, 1122, 10.1016/j.molcel.2017.02.008 Li, 2015, Condensin I and II complexes license full estrogen receptor α-dependent enhancer activation, Mol Cell, 59, 188, 10.1016/j.molcel.2015.06.002 Hendrix, 2010, Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis, JNCI: J Natl Cancer Inst, 102, 866, 10.1093/jnci/djq153 Li, 2018, Functional implications of Rab27 GTPases in cancer, Cell Commun Signal, 16, 44, 10.1186/s12964-018-0255-9 Wu, 2020, Integrated bioinformatics analysis of expression and gene regulation network of COL12A1 in colorectal cancer, Cancer Med, 9, 4743, 10.1002/cam4.2899 Gao, 2019, Clinical roles of miR-136-5p and its target metadherin in thyroid carcinoma, Am J Transl Res, 11, 6754 Zhang, 2022 Narayanan, 2020, Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance, Drug Resist Updates, 48, 10.1016/j.drup.2019.100663 Pan, 2020, Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin–proteasomal degradation of COX-2, Cancer Lett, 482, 102, 10.1016/j.canlet.2019.11.003 Lu, 2019, Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis, Pathol Res Pract, 215, 10.1016/j.prp.2019.152475 Miller, 2009, Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole, J Clin Oncol, 27, 1382, 10.1200/JCO.2008.16.8849 Wang, 2021, Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer, Biosci Rep, 41, 10.1042/BSR20203020 Huang, 2020, Multiple omics analysis of the protective effects of SFN on estrogen-dependent breast cancer cells, Mol Biol Rep, 47, 3331, 10.1007/s11033-020-05403-9 Stephens, 2012, The landscape of cancer genes and mutational processes in breast cancer, Nature, 486, 400, 10.1038/nature11017 Oshi, 2020, G2M cell cycle pathway score as a prognostic biomarker of metastasis in estrogen receptor (ER)-Positive breast cancer, Int J Mol Sci, 21, 2921, 10.3390/ijms21082921 Wang, 2020, DEAD-box RNA helicase 39 promotes invasiveness and chemoresistance of ER-positive breast cancer, J Cancer, 11, 1846, 10.7150/jca.37247 Meyer, 2020, Prevention of DNA replication stress by CHK1 leads to chemoresistance despite a DNA repair defect in homologous recombination in breast cancer, Cells, 9, 238, 10.3390/cells9010238 Oakes, 2020, Endoplasmic reticulum stress signaling in cancer cells, Am J Pathol, 190, 934, 10.1016/j.ajpath.2020.01.010 Mongre, 2020, Exploring the role of TRIP-brs in human breast cancer: an investigation of expression, clinicopathological significance, and prognosis, Molecular Therapy - Oncolytics, 19, 105, 10.1016/j.omto.2020.09.003 Tang, 2020, The role of upregulated miR-375 expression in breast cancer: an in vitro and in silico study, Pathol Res Pract, 216 Chang, 2020, Pathway mutations in breast cancer using whole-exome sequencing, Oncol Res, 28, 107, 10.3727/096504019X15698362825407 Leung, 2021, Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair, Brain Commun, 3, fcab117, 10.1093/braincomms/fcab117 Finlay-Schultz, 2017, Breast cancer suppression by progesterone receptors is mediated by their modulation of estrogen receptors and RNA polymerase III, Cancer Res, 77, 4934, 10.1158/0008-5472.CAN-16-3541 Zhong, 2019, Identification of novel mRNA-miRNA-lncRNA competing endogenous RNA network associated with prognosis of breast cancer, Epigenomics, 11, 1501, 10.2217/epi-2019-0209 Zhang, 2021, Effect of sodium chloride on the expression of genes involved in the salt tolerance of Bacillus sp. strain “SX4” isolated from salinized greenhouse soil, Open Chem, 19, 9, 10.1515/chem-2020-0181 Ge, 2019, Current status and challenges of NRF2 as a potential therapeutic target for diabetic cardiomyopathy, Int Heart J, 60, 512, 10.1536/ihj.18-476 Schultz, 2020, Cancer frequency in patients with spinocerebellar ataxia type 10, Park Relat Disord, 76, 1, 10.1016/j.parkreldis.2020.05.032